- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07801989
Alaska Alliance for Community Engagement Phase II: Partnership for Action Toward Health (AK ACE-PATH)
2026년 8월 30일 업데이트: University of Alaska Fairbanks
Alaska Alliance for Community Engagement Phase II: Protecting Health in the American Arctic: Implementing Localized Solutions to Promote Health and Prevent Chronic Disease in Rural Alaska
The AK ACE-PATH Phase II study aims to pilot and implement a novel intervention, Tools for Arctic Health Promotion (TAHP), to address Alaska Native (AN) community priorities related to local health and community-level resilience.
연구 개요
상세 설명
In Phase I of AK ACE, community partners identified and prioritized local stressors through a consensus-based process.
Building on these findings, Phase II will implement interventions targeting the highest-priority stressors through modules designed to improve health outcomes.This study addresses a critical gap in understanding local health and mental health among AN populations facing rapid social change and overlapping public health challenges.
The project focuses on developing community-driven solutions to improve physiological and mental health, particularly among youth, and to prevent chronic disease across the lifespan in rural Alaska.
To achieve these goals, the study will develop and implement Tools for Arctic Health Promotion (TAHP), a novel intervention integrating data-driven tools and evidence-based community strategies.
TAHP will support structured community engagement and deliver manualized health activities to approximately 410 adults and youth across five rural AN communities.
The TAHP intervention will be evaluated through a feasibility pilot in one community and a paired dynamic waitlisted design (DWLD) across four additional communities.
Behavioral and biological measures will assess individual- and community-level impacts on chronic disease prevention and mental health promotion.
연구 유형
중재적
등록 (추정된)
360
단계
- 1단계
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 연락처
- 이름: Stacy Rasmus, PhD
- 전화번호: 907-328-8919
- 이메일: smrasmus@alaska.edu
연구 연락처 백업
- 이름: Hannah Robinson, MPH
- 전화번호: 731-400-3539
- 이메일: hrobinson3@alaska.edu
연구 장소
-
-
Alaska
-
Fairbanks, Alaska, 미국, 99775
- University of Alaska Fairbanks
-
연락하다:
- Maria Stejskal
- 전화번호: 907-474-6230
- 이메일: mtrussell@alaska.edu
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
예
설명
Inclusion Criteria:
- Self-identify as a permanent resident of the study community
- Be a youth between the ages of 12-17 years or an adult 18+
- Be able to provide written informed consent
Exclusion Criteria:
- Does not have permanent residence in the community or has lived in the community less than 5 years
- Is unable to provide written informed consent
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Enrollment in TAHP
The study will enroll 360 participants from four unique community settings to receive the TAHP intervention.
The study design will make use of a dynamic wait-listed design (DWLD) with 360 participants assessed with behavioral and community-level measures at four time points: baseline (B), intervention midpoint (T1), Intervention end (T2) and 12-month follow-up (T3).
|
The TAHP intervention will utilize a valid measure of rural AN community-level protective factors (Allen, et al., 2025), and an evidence-based toolkit containing strategies proven to increase mental health and well-being in rural AN communities (Allen, Charles, et al., 2023).
A formalized community engaged process will generate new intervention activities that integrate cutting-edge science to address local health priorities.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Perceived Stress Scale Questionnaire will measure individual-level indicators of stress that we hypothesize will decrease over time with intervention participation
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The NIH Toolbox Perceived Stress Scale is a standardized tool designed to assess how unpredictable, uncontrollable, and overloaded individuals feel in their lives.
We will analyze how individual stress indicators are mitigated over time by intervention participation.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
General Life Satisfaction Scale will measure individual level indicators of life satisfaction that we hypothesize will increase with intervention participation
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The NIH Toolbox General Life Satisfaction Scale is a tool designed to assess an individual's cognitive evaluation of their life experiences and overall satisfaction.
We will assess how the intervention mitigates life satisfaction with individuals who participate.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
We will assess if depression decreases with intervention participation using the PHQ-9 Questionnaire
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The Patient Health Questionnaire 9 (PHQ-9) measures the frequency of depressed mood and anhedonia over the past two weeks.
We will assess how the intervention impacts depressive symptoms with individual participation.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
We will assess if anxiety symptoms decrease with intervention participation using the GAD-7
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The Generalized Anxiety Disorder 7-Item (GAD-7) Screener will be given at every time point to assess how the intervention mitigates anxiety with individual participants
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
We will assess if food security increases using the food security index from the PhenX Toolkit
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The PhenX Toolkit includes standardized measures for assessing food security, which is crucial for understanding social determinants of health.
We will use items from the standardized food security tools to evaluate how food access impacts health outcomes and if food security increases with individual participation in the intervention.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
We will assess if cultural efficacy increases with individual intervention participation using the Cultural Efficacy Scale.
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The Cultural Efficacy Scale developed by Gonzalez, Sittner, and Walls in 2022 measures individuals' comfort and access to cultural and traditional resources, particularly within Indigenous communities.
This scale consists of 7-8 items, each with a range of response options from "strongly disagree" to "strongly agree."
We will analyze the data to link cultural efficacy with mental health outcomes (depression and anxiety), highlighting the protective effects of engagement in the intervention.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
We will assess how the intervention increases individual protective factors using the Multi-Cultural Mastery Scale
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The Multicultural Mastery Scale, developed by Allen and Mohatt, assesses coping strategies through self-mastery and communal mastery dimensions.
It includes subscales that differentiate between mastery related to family and friends, highlighting the importance of social networks.
We will utilize data from this scale to determine how the intervention increases positive coping and builds social networks connections in individuals who participate.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
We will assess how intervention participation increases social and cultural connectedness using the Awareness of Connectedness Scale
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The Awareness of Connectedness Scale (ACS), developed by Mohatt and Fok, measures an individual's awareness of their interrelatedness with family, community, and the natural environment.
This scale is particularly focused on cultural aspects of wellness and healing among Alaska Native people, providing insights into their social and ecological connections.
We will utilize data from the scale to assess the intervention impacts on building connectedness among individual participants.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
|
We will assess how the intervention increases reasons for life and meaning and purpose using the Reasons for Life Scale
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The Reasons for Life Scale (RFL), developed by Allen and Rasmus, focuses on cultural strengths and protective factors against suicide, particularly among Alaska Native people.
It emphasizes resilience, cultural teachings, and community recognition as vital components in promoting mental health and preventing suicide.
We will utilize data from scale to assess how the intervention promotes reasons for life and associates with mental health outcomes (depression and anxiety) in individuals who participate in activities.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
We will assess the increase in community-level factors that are protective and contribute to health outcomes using the Protective Community Scale
기간: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
The Protective Community Scale (PCS), developed by Wexler, Allen, and Rasmus, aims to identify community-level protective factors that can reduce suicide risk among Alaska Native youth.
This scale is part of a broader effort to enhance resilience in these communities through culturally relevant measures and community engagement.
We will analyze data from the PCS to determine if the intervention has mitigated environmental stressors and increased community protection.
|
Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3)
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
We will assess changes to a stress biomarker, cortisol, using Salimetrics OnTimePoint SalivaTM Collection Management application system.
기간: Day 1 (baseline), 8 months (T2) and at 20 months (T3)
|
To measure the impacts of our intervention on biological outcomes, we will assess biomarkers associated with allostatic load - cortisol as an indicator of physiological stress response.
These biomarkers will allow us to evaluate whether participation in the intervention is associated with reduced chronic stress burden and improved mental health (anxiety and depression) over time.
Our proposed saliva collection protocol will involve our research team members administering the saliva kits with youth and adult participants over a 3-day period with multiple tests to capture cortisol levels throughout the day.
Multi-day cortisol levels will be averaged to determine a baseline, and the same process will be used for saliva collection and measurement of cortisol levels at each time point.
|
Day 1 (baseline), 8 months (T2) and at 20 months (T3)
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
간행물 및 유용한 링크
연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (추정된)
2026년 9월 21일
기본 완료 (추정된)
2028년 10월 31일
연구 완료 (추정된)
2029년 4월 30일
연구 등록 날짜
최초 제출
2026년 8월 25일
QC 기준을 충족하는 최초 제출
2026년 8월 30일
처음 게시됨 (실제)
2026년 9월 3일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 9월 3일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 8월 30일
마지막으로 확인됨
2026년 8월 1일
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 6922-06-CH-S001
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
아니요
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .